Lataa...
Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
AIMS: The alarmin S100A8/S100A9 (S100A8/A9) is released by activated monocytes/macrophages and neutrophils in the setting lymphocytic myocarditis (MC). We recently demonstrated its therapeutic potential in experimental acute MC. Now, we investigated the diagnostic relevance of S100A8/A9 serum levels...
Tallennettuna:
| Julkaisussa: | ESC Heart Fail |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373886/ https://ncbi.nlm.nih.gov/pubmed/32462801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12760 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|